-
1
-
-
0027444652
-
A predictive model for aggressive non-Hodgkin's lymphoma
-
The International Non-Hodgkin's Lymphoma Prognostic Factors Project
-
-(1993) A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 329:987-994
-
(1993)
N Engl J Med
, vol.329
, pp. 987-994
-
-
-
2
-
-
85047692516
-
Signalling pathways of the TNF superfamily: A double-edged sword
-
10.1038/nri1184 1:CAS:528:DC%2BD3sXmvVWmtb0%3D 12949498
-
BB Aggarwal 2003 Signalling pathways of the TNF superfamily: a double-edged sword Nat Rev Immunol 3 745 756 10.1038/nri1184 1:CAS:528:DC%2BD3sXmvVWmtb0%3D 12949498
-
(2003)
Nat Rev Immunol
, vol.3
, pp. 745-756
-
-
Aggarwal, B.B.1
-
3
-
-
0034894958
-
Inhibition of interleukin 10 by Rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis
-
1:CAS:528:DC%2BD3MXjtVOnsr0%3D 11297268
-
S Alas C Emmanouilides B Bonavida 2001 Inhibition of interleukin 10 by Rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis Clin Cancer Res 7 709 723 1:CAS:528:DC%2BD3MXjtVOnsr0%3D 11297268
-
(2001)
Clin Cancer Res
, vol.7
, pp. 709-723
-
-
Alas, S.1
Emmanouilides, C.2
Bonavida, B.3
-
4
-
-
0026784556
-
Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10
-
1:CAS:528:DyaK3sXlsl2gsw%3D%3D 1325212
-
D Benjamin TJ Knobloch MA Dayton 1992 Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10 Blood 80 1289 1298 1:CAS:528:DyaK3sXlsl2gsw%3D%3D 1325212
-
(1992)
Blood
, vol.80
, pp. 1289-1298
-
-
Benjamin, D.1
Knobloch, T.J.2
Dayton, M.A.3
-
5
-
-
0027434991
-
Serum interleukin-10 in non-Hodgkin's lymphoma: A prognostic factor
-
1:STN:280:DyaK2c%2Fgtlaksg%3D%3D 8400266
-
JY Blay N Burdin F Rousset, et al. 1993 Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor Blood 82 2169 2174 1:STN:280:DyaK2c%2Fgtlaksg%3D%3D 8400266
-
(1993)
Blood
, vol.82
, pp. 2169-2174
-
-
Blay, J.Y.1
Burdin, N.2
Rousset, F.3
-
6
-
-
0042449063
-
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphoma
-
1:STN:280:DC%2BD3c%2FivF2itg%3D%3D 10561185
-
BD Cheson SJ Horning B Coiffier, et al. 1999 Report of an international workshop to standardize response criteria for non-Hodgkin's lymphoma J Clin Oncol 17 1244 1253 1:STN:280:DC%2BD3c%2FivF2itg%3D%3D 10561185
-
(1999)
J Clin Oncol
, vol.17
, pp. 1244-1253
-
-
Cheson, B.D.1
Horning, S.J.2
Coiffier, B.3
-
7
-
-
0024379544
-
LNH-84 regimen: A multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma
-
1:STN:280:DyaL1MzivVCktA%3D%3D 2474057
-
B Coiffier C Gisselbrecht R Herbrecht, et al. 1989 LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma J Clin Oncol 7 1018 1026 1:STN:280:DyaL1MzivVCktA%3D%3D 2474057
-
(1989)
J Clin Oncol
, vol.7
, pp. 1018-1026
-
-
Coiffier, B.1
Gisselbrecht, C.2
Herbrecht, R.3
-
8
-
-
0037165261
-
Chop chemotherapy plus rituximab compared with chop alone in elderly patients with diffuse large-B-cell lymphoma
-
DOI 10.1056/NEJMoa011795
-
B Coiffier E Lepage J Briere, et al. 2002 CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma N Engl J Med 346 235 242 10.1056/NEJMoa011795 1:CAS:528: DC%2BD38XmslGgsw%3D%3D 11807147 (Pubitemid 34438862)
-
(2002)
New England Journal of Medicine
, vol.346
, Issue.4
, pp. 235-242
-
-
Coiffier, B.1
Lepage, E.2
Briere, J.3
Herbrecht, R.4
Tilly, H.5
Bouabdallah, R.6
Morel, P.7
Van Den Neste, E.8
Salles, G.9
Gaulard, P.10
Reyes, F.11
Lederlin, P.12
Gisselbrecht, C.13
-
9
-
-
36349003600
-
Impact of interleukin-10 polymorphisms (-1082 and -3575) on the survival of patients with lymphoid neoplasms
-
DOI 10.3324/haematol.11350
-
E Domingo-Domènech Y Benavente E González-Barca, et al. 2007 Impact of interleukin-10 polymorphisms (-1082 and -3575) on the survival of patients with lymphoid neoplasms Haematologica 92 1475 1481 10.3324/haematol.11350 18024395 (Pubitemid 350144122)
-
(2007)
Haematologica
, vol.92
, Issue.11
, pp. 1475-1481
-
-
Domingo-Domenech, E.1
Benavente, Y.2
Gonzalez-Barca, E.3
Montalban, C.4
Guma, J.5
Bosch, R.6
Wang, S.S.7
Lan, Q.8
Whitby, D.9
De Sevilla, A.F.10
Rothman, N.11
De Sanjose, S.12
-
10
-
-
0029075329
-
Tumor necrosis factor ligand superfamily: Involvement in the pathology of malignant lymphomas
-
1:CAS:528:DyaK2MXmtlOmtrs%3D 7780126
-
HJ Gruss SK Dower 1995 Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas Blood 85 3378 3404 1:CAS:528:DyaK2MXmtlOmtrs%3D 7780126
-
(1995)
Blood
, vol.85
, pp. 3378-3404
-
-
Gruss, H.J.1
Dower, S.K.2
-
11
-
-
12244269738
-
Cytokines and their role in lymphoid development, differentiation and homeostasis
-
DOI 10.1097/00130832-200212000-00004
-
SR Hofmann R Ettinger YJ Zhou, et al. 2002 Cytokines and their role in lymphoid development, differentiation and homeostasis Curr Opin Allergy Clin Immunol 2 495 506 10.1097/00130832-200212000-00004 14752332 (Pubitemid 36105812)
-
(2002)
Current Opinion in Allergy and Clinical Immunology
, vol.2
, Issue.6
, pp. 495-506
-
-
Hofmann, S.R.1
Ettinger, R.2
Zhou, Y.-J.3
Gadina, M.4
Lipsky, P.5
Siegel, R.6
Candotti, F.7
O'Shea, J.J.8
-
12
-
-
33646410446
-
Clinical significance of serum Th1-, Th2- and regulatory T cells-associated cytokines in adult T-cell leukemia/lymphoma: High interleukin-5 and -10 levels are significant unfavorable prognostic factors
-
10.1002/ijc.21688 1:CAS:528:DC%2BD28XksVKlu74%3D 16425276
-
A Inagaki T Ishida T Ishii, et al. 2006 Clinical significance of serum Th1-, Th2- and regulatory T cells-associated cytokines in adult T-cell leukemia/lymphoma: high interleukin-5 and -10 levels are significant unfavorable prognostic factors Int J Cancer 118 3054 3061 10.1002/ijc.21688 1:CAS:528:DC%2BD28XksVKlu74%3D 16425276
-
(2006)
Int J Cancer
, vol.118
, pp. 3054-3061
-
-
Inagaki, A.1
Ishida, T.2
Ishii, T.3
-
13
-
-
25844459154
-
NF-κB: Linking inflammation and immunity to cancer development and progression
-
DOI 10.1038/nri1703
-
M Karin FR Greten 2005 NF-kappaB: linking inflammation and immunity to cancer development and progression Nat Rev Immunol 5 749 759 10.1038/nri1703 1:CAS:528:DC%2BD2MXhtVGrurvL 16175180 (Pubitemid 41400849)
-
(2005)
Nature Reviews Immunology
, vol.5
, Issue.10
, pp. 749-759
-
-
Karin, M.1
Greten, F.R.2
-
14
-
-
33646566836
-
Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma
-
DOI 10.1182/blood-2005-10-4160
-
Q Lan T Zheng N Rothman, et al. 2006 Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma Blood 107 4101 4108 10.1182/blood-2005-10-4160 1:CAS:528:DC%2BD28XkvFWgs74%3D 16449530 (Pubitemid 43726819)
-
(2006)
Blood
, vol.107
, Issue.10
, pp. 4101-4108
-
-
Lan, Q.1
Zheng, T.2
Rothman, N.3
Zhang, Y.4
Wang, S.S.5
Shen, M.6
Berndt, S.I.7
Zahm, S.H.8
Holford, T.R.9
Leaderer, B.10
Yeager, M.11
Welch, R.12
Boyle, P.13
Zhang, B.14
Zou, K.15
Zhu, Y.16
Chanock, S.17
-
15
-
-
1942521249
-
Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma
-
DOI 10.1182/blood-2003-06-1850
-
E Lech-Maranda L Baseggio J Bienvenu, et al. 2004 Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma Blood 103 3354 3529 10.1182/blood-2003-06-1850 (Pubitemid 38525688)
-
(2004)
Blood
, vol.103
, Issue.9
, pp. 3529-3534
-
-
Lech-Maranda, E.1
Baseggio, L.2
Bienvenu, J.3
Charlot, C.4
Berger, F.5
Rigal, D.6
Warzocha, K.7
Coiffier, B.8
Salles, G.9
-
16
-
-
33746083294
-
Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma
-
1:CAS:528:DC%2BD28XksVWktrc%3D 16613764
-
E Lech-Maranda J Bienvenu AS Michallet, et al. 2006 Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma Eur Cytokine Netw 17 60 66 1:CAS:528:DC%2BD28XksVWktrc%3D 16613764
-
(2006)
Eur Cytokine Netw
, vol.17
, pp. 60-66
-
-
Lech-Maranda, E.1
Bienvenu, J.2
Michallet, A.S.3
-
17
-
-
1642554780
-
The multifaceted relationship between IL-10 and adaptive immunity: Putting together the pieces of a puzzle
-
DOI 10.1016/j.cytogfr.2003.11.001
-
S Mocellin F Marincola CR Rossi, et al. 2004 The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle Cytokine Growth Factor Rev 15 61 76 10.1016/j.cytogfr.2003.11.001 1:CAS:528:DC%2BD2cXmvFKktQ%3D%3D 14746814 (Pubitemid 38121291)
-
(2004)
Cytokine and Growth Factor Reviews
, vol.15
, Issue.1
, pp. 61-76
-
-
Mocellin, S.1
Marincola, F.2
Rossi, C.R.3
Nitti, D.4
Lise, M.5
-
18
-
-
0035062021
-
Interleukin-10 and the interleukin-10 receptor
-
DOI 10.1146/annurev.immunol.19.1.683
-
KW Moore R de Waal Malefyt RL Coffman, et al. 2001 Interleukin-10 and the interleukin-10 receptor Annu Rev Immunol 19 683 765 10.1146/annurev.immunol.19. 1.683 1:CAS:528:DC%2BD3MXivFKgu70%3D 11244051 (Pubitemid 32368050)
-
(2001)
Annual Review of Immunology
, vol.19
, pp. 683-765
-
-
Moore, K.W.1
De Waal Malefyt, R.2
Coffman, R.L.3
O'Garra, A.4
-
19
-
-
0037409043
-
High tumor necrosis factor-α levels in the patients with Epstein-Barr virus-associated peripheral T-cell proliferative disease/lymphoma
-
DOI 10.1016/S0145-2126(02)00266-7, PII S0145212602002667
-
A Mori S Takao J Pradutkanchana, et al. 2003 High tumor necrosis factor-alpha levels in the patients with Epstein-Barr virus-associated peripheral T-cell proliferative disease/lymphoma Leuk Res 27 493 498 10.1016/S0145-2126(02)00266-7 1:CAS:528:DC%2BD3sXitVymsrY%3D 12648508 (Pubitemid 36315780)
-
(2003)
Leukemia Research
, vol.27
, Issue.6
, pp. 493-498
-
-
Mori, A.1
Takao, S.2
Pradutkanchana, J.3
Kietthubthew, S.4
Mitarnun, W.5
Ishida, T.6
-
20
-
-
0037698992
-
Rituximab plus CHOP (R-CHOP) overcomes bcl-2-associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)
-
DOI 10.1182/blood-2002-11-3442
-
N Mounier J Briere C Gisselbrecht, et al. 2003 Rituximab plus CHOP (R-CHOP) overcomes bcl-2-associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL) Blood 101 4279 4284 10.1182/blood-2002-11-3442 1:CAS:528:DC%2BD3sXktFKht7k%3D 12576316 (Pubitemid 36857789)
-
(2003)
Blood
, vol.101
, Issue.11
, pp. 4279-4284
-
-
Mounier, N.1
Briere, J.2
Gisselbrecht, C.3
Emile, J.-F.4
Lederlin, P.5
Sebban, C.6
Berger, F.7
Bosly, A.8
Morel, P.9
Tilly, H.10
Bouabdallah, R.11
Reyes, F.12
Gaulard, P.13
Coiffier, B.14
-
21
-
-
8544247939
-
The effects of IL-2, IL-6 and IL-10 levels on prognosis in patients with aggressive non-Hodgkin's lymphoma (NHL)
-
1:STN:280:DC%2BD2cnitVGksA%3D%3D 15595640
-
F Ozdemir F Aydin M Yilmaz, et al. 2004 The effects of IL-2, IL-6 and IL-10 levels on prognosis in patients with aggressive non-Hodgkin's lymphoma (NHL) J Exp Clin Cancer Res 23 485 488 1:STN:280:DC%2BD2cnitVGksA%3D%3D 15595640
-
(2004)
J Exp Clin Cancer Res
, vol.23
, pp. 485-488
-
-
Ozdemir, F.1
Aydin, F.2
Yilmaz, M.3
-
22
-
-
0037644804
-
Biological functions of tumor necrosis factor cytokines and their receptors
-
DOI 10.1016/S1359-6101(03)00022-4
-
K Pfeffer 2003 Biological functions of tumor necrosis factor cytokines and their receptors Cytokine Growth Factor Rev 14 185 191 10.1016/S1359-6101(03) 00022-4 1:CAS:528:DC%2BD3sXkt1Ghsr0%3D 12787558 (Pubitemid 36693140)
-
(2003)
Cytokine and Growth Factor Reviews
, vol.14
, Issue.3-4
, pp. 185-191
-
-
Pfeffer, K.1
-
23
-
-
29744459902
-
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: A report from the InterLymph Consortium
-
DOI 10.1016/S1470-2045(05)70434-4, PII S1470204505704344
-
N Rothman CF Skibola SS Wang, et al. 2006 Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium Lancet Oncol 7 27 38 10.1016/S1470-2045(05)70434-4 1:CAS:528:DC%2BD28XksFOn 16389181 (Pubitemid 43025390)
-
(2006)
Lancet Oncology
, vol.7
, Issue.1
, pp. 27-38
-
-
Rothman, N.1
Skibola, C.F.2
Wang, S.S.3
Morgan, G.4
Lan, Q.5
Smith, M.T.6
Spinelli, J.J.7
Willett, E.8
De Sanjose, S.9
Cocco, P.10
Berndt, S.I.11
Brennan, P.12
Brooks-Wilson, A.13
Wacholder, S.14
Becker, N.15
Hartge, P.16
Zheng, T.17
Roman, E.18
Holly, E.A.19
Boffetta, P.20
Armstrong, B.21
Cozen, W.22
Linet, M.23
Bosch, X.F.24
Ennas, M.G.25
Holford, T.R.26
Gallagher, R.P.27
Rollinson, S.28
Bracci, P.M.29
Cerhan, J.R.30
Whitby, D.31
Moore, P.S.32
Leaderer, B.33
Lai, A.34
Spink, C.35
Davis, S.36
Bosch, R.37
Scarpa, A.38
Zhang, Y.39
Severson, R.K.40
Yeager, M.41
Chanock, S.42
Nieters, A.43
more..
-
24
-
-
0029887909
-
Elevated circulating levels of TNF-alpha and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients
-
10.1046/j.1365-2141.1996.5181059.x 1:STN:280:DyaK283htlyitQ%3D%3D 8639428
-
G Salles J Bienvenu Y Bastion, et al. 1996 Elevated circulating levels of TNF-alpha and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients Br J Haematol 93 352 359 10.1046/j.1365-2141.1996.5181059. x 1:STN:280:DyaK283htlyitQ%3D%3D 8639428
-
(1996)
Br J Haematol
, vol.93
, pp. 352-359
-
-
Salles, G.1
Bienvenu, J.2
Bastion, Y.3
-
25
-
-
0028012062
-
Prognostic factors in aggressive non-Hodgkin's lymphoma: Who has "high-risk" disease?
-
1:STN:280:DyaK2c7mt1KisA%3D%3D 8118021
-
MA Shipp 1994 Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high-risk" disease? Blood 83 1165 1173 1:STN:280: DyaK2c7mt1KisA%3D%3D 8118021
-
(1994)
Blood
, vol.83
, pp. 1165-1173
-
-
Shipp, M.A.1
-
26
-
-
0030447760
-
Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors
-
N Voorzanger R Touitou E Garcia, et al. 1996 Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors Cancer Res 56 5499 5505 1:CAS:528:DyaK28Xntl2mtbw%3D 8968107 (Pubitemid 27011386)
-
(1996)
Cancer Research
, vol.56
, Issue.23
, pp. 5499-5505
-
-
Voorzanger, N.1
Touitou, R.2
Garcia, E.3
Delecluse, H.-J.4
Rousset, F.5
Joab, I.6
Favrot, M.C.7
Blay, J.-Y.8
-
27
-
-
34250339160
-
Immune mechanisms in non-Hodgkin lymphoma: Joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors
-
DOI 10.1158/0008-5472.CAN-06-4752
-
SS Wang W Cozen JR Cerhan, et al. 2007 Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors Cancer Res 67 5042 5054 10.1158/0008-5472.CAN- 06-4752 1:CAS:528:DC%2BD2sXltl2gtrc%3D 17510437 (Pubitemid 46910215)
-
(2007)
Cancer Research
, vol.67
, Issue.10
, pp. 5042-5054
-
-
Wang, S.S.1
Cozen, W.2
Cerhan, J.R.3
Colt, J.S.4
Morton, L.M.5
Engels, E.A.6
Davis, S.7
Severson, R.K.8
Rothman, N.9
Chanock, S.J.10
Hartge, P.11
-
28
-
-
0027131207
-
Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis
-
1:CAS:528:DyaK2cXnsFWktQ%3D%3D 8258695
-
C Wanidworanun W Strober 1993 Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis J Immunol 151 6853 6861 1:CAS:528:DyaK2cXnsFWktQ%3D%3D 8258695
-
(1993)
J Immunol
, vol.151
, pp. 6853-6861
-
-
Wanidworanun, C.1
Strober, W.2
-
29
-
-
0031833240
-
The tumor necrosis factor signaling complex: Choosing a path toward cell death or cell proliferation
-
10.3109/10428199809058384 1:CAS:528:DC%2BD3cXis1arsro%3D 9638978
-
K Warzocha G Salles 1998 The tumor necrosis factor signaling complex: choosing a path toward cell death or cell proliferation Leuk Lymphoma 29 81 92 10.3109/10428199809058384 1:CAS:528:DC%2BD3cXis1arsro%3D 9638978
-
(1998)
Leuk Lymphoma
, vol.29
, pp. 81-92
-
-
Warzocha, K.1
Salles, G.2
-
30
-
-
0030796185
-
Prognostic significance of TNF-alpha and its p55 soluble receptor in malignant lymphomas
-
9209418
-
K Warzocha G Salles J Bienvenu, et al. 1997 Prognostic significance of TNF-alpha and its p55 soluble receptor in malignant lymphomas Leukemia 11 suppl 3 441 443 9209418
-
(1997)
Leukemia
, vol.11
, Issue.SUPPL 3
, pp. 441-443
-
-
Warzocha, K.1
Salles, G.2
Bienvenu, J.3
-
31
-
-
0031037239
-
Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients
-
1:STN:280:DyaK2s7nvVOgug%3D%3D 9053471
-
K Warzocha G Salles J Bienvenu, et al. 1997 Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients J Clin Oncol 15 499 508 1:STN:280:DyaK2s7nvVOgug%3D%3D 9053471
-
(1997)
J Clin Oncol
, vol.15
, pp. 499-508
-
-
Warzocha, K.1
Salles, G.2
Bienvenu, J.3
-
32
-
-
0032525156
-
Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome
-
1:CAS:528:DyaK1cXjtFersro%3D 9572991
-
K Warzocha P Ribeiro J Bienvenu, et al. 1998 Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome Blood 91 3574 3581 1:CAS:528:DyaK1cXjtFersro%3D 9572991
-
(1998)
Blood
, vol.91
, pp. 3574-3581
-
-
Warzocha, K.1
Ribeiro, P.2
Bienvenu, J.3
-
33
-
-
0037962020
-
Clinical implications of the tumor necrosis factor family in benign and malignant hematologic disorders: A short review
-
DOI 10.1002/cncr.11524
-
A Younes BB Aggarwall 2003 Clinical implications of the tumor necrosis factor family in benign and malignant hematologic disorders Cancer 98 458 467 10.1002/cncr.11524 1:CAS:528:DC%2BD3sXmsV2mtbk%3D 12879461 (Pubitemid 36885984)
-
(2003)
Cancer
, vol.98
, Issue.3
, pp. 458-467
-
-
Younes, A.1
Aggarwall, B.B.2
|